Skip to main content

Table 2 Percentages of relative homologous and heterologous seroneutralization titers

From: Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions

Immunised serum BTV serotype
BTV1 BTV2 BTV4 BTV8 BTV9 BTV16
Control 0.52 1.11 0.55 0.44 0 3.54
BTV1 100 1.11 8.85 25 0 3.54
BTV2 1.3 100 3.15 0.44 0 3.54
BTV4 0.65 0.88 100 0.44 0 12.5
BTV8 10.36 12.5 25 100 6.25 3.54
BTV9 2.61 3.1 0.77 0.44 100 3.54
BTV16 18.34 12.39 0.83 0.44 0 100